Mixed effect models revealed a significant effect of diagnosis and location on both MAO-B and GFAP immunoreactivity, demonstrating that MAO-B expression is higher in AD versus CTRL, especially in the GFAP+ reactive astrocytes surrounding and penetrating the dense-core Aβ plaques of AD donors (Fig. 6). Here, GFAP is linked to Alzheimer disease.